Form 4: RxSight CFO Sells Shares
Insider Transaction (Form 4)
Mark Wilterding, Chief Financial Officer of RxSight, Inc., sold 7,765 shares of common stock on August 31, 2026 for $6.96 per share.
Summary
- Option exercise/conversion: acquired 20,441 Common Stock on August 31, 2026; holds 32,814 after (Direct).
- Open-market sale: disposed of 7,765 Common Stock at $6.96 ($54,044) on September 2, 2026; holds 25,049 after (Direct).
- Option exercise/conversion: disposed of 20,441 Restricted Stock Unit on August 31, 2026; holds 122,646 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $54,044 of stock on the open market.
Insider Transactions
Mark Wilterding — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Option exercise/conversion | Common Stock | 20,441 | — | — | 32,814 |
| 2026-09-02 | Open-market sale | Common Stock | 7,765 | $7 | $54.0K | 25,049 |
| 2026-08-31 | Option exercise/conversion | Restricted Stock Unit | 20,441 | — | — | 122,646 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Option exercise/conversion (20,441 shares) |
| 2026-09-02 | Open-market sale (7,765 shares) |
| 2026-08-31 | Option exercise/conversion (20,441 shares) |
Keywords
insider transaction, Form 4, RXST, RxSight, Inc., bearish, Mark Wilterding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.